Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency.
Verbsky JW, Hintermeyer MK, Simpson PM, Feng M, Barbeau J, Rao N, Cool CD, Sosa-Lozano LA, Baruah D, Hammelev E, Busalacchi A, Rymaszewski A, Woodliff J, Chen S, Bausch-Jurken M, Routes JM.
Verbsky JW, et al. Among authors: routes jm.
J Allergy Clin Immunol. 2021 Feb;147(2):704-712.e17. doi: 10.1016/j.jaci.2020.07.021. Epub 2020 Aug 1.
J Allergy Clin Immunol. 2021.
PMID: 32745555